Latest Articles
-
Can Axon Stock Jump 50%?
For questions about this article or underlying research, email help@trefis.com. Part of the case for a 50% jump in Axon Enterprise (AXON) stock rests on a business you may not connect with it: counter-drone systems, a category Axon added at the ...
-
Why Should You Think About CSX Differently Now?
For questions about this article or underlying research, email help@trefis.com. CSX Corp. (CSX) stock is priced at 26.8 times earnings, against 22.6 for the S&P 500. Investors paying that price need to know what they are buying, and the rai...
-
Can Cipher Digital Stock Fall 50%?
For questions about this article or underlying research, email help@trefis.com. Cipher Digital (CIFR) owed $5.6 billion at the end of June 2026, climbing from $189 million a year earlier. The chance of a 50% drop from current levels rests in pa...
-
Does Ormat Stock’s Valuation Make Sense?
For questions about this article or underlying research, email help@trefis.com. Ormat Technologies (ORA) stock trades at 44.5 times its earnings over the last twelve months, compared with 22.6 for the S&P 500. Buyers paying that price for t...
-
Can Avis Budget Stock Fall 50%?
For questions about this article or underlying research, email help@trefis.com. Shares of Avis Budget (CAR) have lost 33.1% since July 30, 2026, trailing a 4.4% gain for the S&P 500, and the company has not reported results since. A further ...
-
Should You Pick Honeywell Stock Over Its Competitors?
For questions about this article or underlying research, email help@trefis.com. If you are choosing among large industrial stocks, Honeywell International (HON) looks hard to pass over on paper. Honeywell’s reported figures put it first on...
-
What Needs To Be True To Buy Accenture Stock Now?
For questions about this article or underlying research, email help@trefis.com. Investors eyeing Accenture (ACN) probably fear that AI allows clients to complete the same work with fewer consultants. Management says the new business AI generates...
-
Does The Move In CrowdStrike Stock Change Anything?
For questions about this article or underlying research, email help@trefis.com. Shares of CrowdStrike (CRWD) returned 95.0% in the year to October 28, 2026, compared with 13.7% for the S&P 500. The cybersecurity company recorded its largest ...
-
Is Sherwin-Williams A Good Long-Term Stock?
For questions about this article or underlying research, email help@trefis.com. Sherwin-Williams (SHW) stock lost 3.6% over the past year, dividends included, while the S&P 500 returned 14.0%. For a long-term holder, the case for the stock ...
-
What Could Lift Newmont Stock?
For questions about this article or underlying research, email help@trefis.com. Newmont (NEM) stock returned 46.2% over the twelve months to October 28, 2026, beating the S&P 500’s 14.0% gain. If you own the gold miner after that run,...
-
Is It A Mistake To Buy Cardinal Health Stock At A High?
For questions about this article or underlying research, email help@trefis.com. Most investors know the rule: buy low, and never at the top. Cardinal Health (CAH) stock closed at a 52-week high of $257.55 on October 20, 2026. The stock closed at...
-
Can GitLab Stock Get Back To Where It Was?
For questions about this article or underlying research, email help@trefis.com. GitLab (GTLB) stock trades at less than half its November 2021 closing high. If you own the stock, you likely still measure your investment against that peak, treat...
-
What Just Happened To LPL Financial Stock?
For questions about this article or underlying research, email help@trefis.com. LPL Financial (LPLA) stock fell 15.2% on Wednesday, October 28, 2026, as the S&P 500 gained 0.3%. The selloff followed the company’s October 27 release of...
-
What Is Behind The Move In Vertiv Stock?
For questions about this article or underlying research, email help@trefis.com. Vertiv (VRT), the maker of power and cooling systems for data centers, climbed 16.5% on Wednesday, October 28, 2026, outpacing the S&P 500’s 0.3% gain. Th...
-
What Is Behind Liquidia’s Lead Over Its Industry?
For questions about this article or underlying research, email help@trefis.com. Over the past five years, one drugmaker outperformed all 60 of its measurable pharmaceutical peers. That company is Liquidia Corporation (LQDA) (LQDA), the manufactu...
